Your browser does not support javascript. This is required for using the requested form.
Registration form Research Project 1 master BPS (academic year 2021-2022)
First name
*
Last name
*
Student number
*
Email
*
Would you like to start your RP1 in October (immediately after the Introduction course BPS - September edition)
*
yes
no
Please explain why you don't want to (or can't) start your RP1 in October. When will you be able to start your RP1? NOTE: We highly recommend students starting with their RP1 as soon as possible after the start of their master programme.
*
What type of research are you (mostly) interested in?
*
fundamental research (this concerns almost all research within the LACDR)
pre-clinical research
clinical research (note: this is usually not the field of a BPS student)
What kind of research would you like to do/learn?
*
computational research
experimental research
a combination of computational/experimental
What level of research are you mostly interested in?
*
research on a molecular level
research on a cellular level
research on the level of the organ/organism
What discipline are you mostly interested in?
*
Biology
Chemistry
Pharmacotherapy (the effect of drugs on the cell/organ/organism)
Selection of research topics
Every students starts his/her master programme of 9 months at the LACDR. Please visit the
website
of the LACDR and learn more about the research conducted at the LACDR. Please select three research topics your interested in, and rank from 1 to 3.
NOTE 1: to increase your chances of being matched to a research topic of your top choice, select research themes of different divisions of the LACDR.
NOTE 2: Unfortunately, the CHDR does not offer RP1 positions at this time.
Top 1 choice
*
<select one>
BioTherapeutics - Biologics Formulation
BioTherapeutics - Cardiovascular and Metabolic Therapeutics
BioTherapeutics - Immune Activation and Tolerance
BioTherapeutics - Skin Barrier and Vaccination
BioTherapeutics - Therapeutic Immunomodulation
BioTherapeutics - Aging and Immunity
BioTherapeutics - Delivery of Biotherapeutics
BioTherapeutics - Prevention of Unstable Atherosclerosis
Drug Discovery and Safety - Cancer Therapeutics and Drug Safety - Topic: Cancer Therapeutics
Drug Discovery and Safety - Cancer Therapeutics and Drug Safety - Topic: Drug Safety
Drug Discovery and Safety - Cancer Drug Target Discovery
Drug Discovery and Safety - Stem Cell Biology and Regenerative Medicine
Drug Discovery and Safety - Computational Drug Discovery
Drug Discovery and Safety - Image-based Computational Biology
Drug Discovery and Safety - Medicinal Chemistry
Drug Discovery and Safety - Molecular Pharmacology
Systems Biomedicine and Pharmacology - Analytical BioSciences and Metabolomics
Systems Biomedicine and Pharmacology - Biomedical Microscale Analytics
Systems Biomedicine and Pharmacology - Medical Systems Biophysics and Bioengineering
Systems Biomedicine and Pharmacology - Predictive Pharmacology
Systems Biomedicine and Pharmacology - Quantitative Clinical Pharmacology
Systems Biomedicine and Pharmacology - Quantitative Pharmacology
Systems Biomedicine and Pharmacology - Systems Pharmacology
Top 2 choice
*
<select one, preferably from another division>
BioTherapeutics - Biologics Formulation
BioTherapeutics - Cardiovascular and Metabolic Therapeutics
BioTherapeutics - Immune Activation and Tolerance
BioTherapeutics - Skin Barrier and Vaccination
BioTherapeutics - Therapeutic Immunomodulation
BioTherapeutics - Aging and Immunity
BioTherapeutics - Delivery of Biotherapeutics
BioTherapeutics - Prevention of Unstable Atherosclerosis
Drug Discovery and Safety - Cancer Therapeutics and Drug Safety - Topic: Cancer Therapeutics
Drug Discovery and Safety - Cancer Therapeutics and Drug Safety - Topic: Drug Safety
Drug Discovery and Safety - Cancer Drug Target Discovery
Drug Discovery and Safety - Stem Cell Biology and Regenerative Medicine
Drug Discovery and Safety - Computational Drug Discovery
Drug Discovery and Safety - Image-based Computational Biology
Drug Discovery and Safety - Medicinal Chemistry
Drug Discovery and Safety - Molecular Pharmacology
Systems Biomedicine and Pharmacology - Analytical BioSciences and Metabolomics
Systems Biomedicine and Pharmacology - Biomedical Microscale Analytics
Systems Biomedicine and Pharmacology - Medical Systems Biophysics and Bioengineering
Systems Biomedicine and Pharmacology - Predictive Pharmacology
Systems Biomedicine and Pharmacology - Quantitative Clinical Pharmacology
Systems Biomedicine and Pharmacology - Quantitative Pharmacology
Systems Biomedicine and Pharmacology - Systems Pharmacology
Top 3 choice
*
<select one, preferably from another division>
BioTherapeutics - Biologics Formulation
BioTherapeutics - Cardiovascular and Metabolic Therapeutics
BioTherapeutics - Immune Activation and Tolerance
BioTherapeutics - Skin Barrier and Vaccination
BioTherapeutics - Therapeutic Immunomodulation
BioTherapeutics - Aging and Immunity
BioTherapeutics - Delivery of Biotherapeutics
BioTherapeutics - Prevention of Unstable Atherosclerosis
Drug Discovery and Safety - Cancer Therapeutics and Drug Safety - Topic: Cancer Therapeutics
Drug Discovery and Safety - Cancer Therapeutics and Drug Safety - Topic: Drug Safety
Drug Discovery and Safety - Cancer Drug Target Discovery
Drug Discovery and Safety - Stem Cell Biology and Regenerative Medicine
Drug Discovery and Safety - Computational Drug Discovery
Drug Discovery and Safety - Image-based Computational Biology
Drug Discovery and Safety - Medicinal Chemistry
Drug Discovery and Safety - Molecular Pharmacology
Systems Biomedicine and Pharmacology - Analytical BioSciences and Metabolomics
Systems Biomedicine and Pharmacology - Biomedical Microscale Analytics
Systems Biomedicine and Pharmacology - Medical Systems Biophysics and Bioengineering
Systems Biomedicine and Pharmacology - Predictive Pharmacology
Systems Biomedicine and Pharmacology - Quantitative Clinical Pharmacology
Systems Biomedicine and Pharmacology - Quantitative Pharmacology
Systems Biomedicine and Pharmacology - Systems Pharmacology
Please motivate your first choice (word limit 400)
*
*
=
Input is required